References 1 ParikhKAntanaviciuteAFawkner-CorbettDJagielowiczMAulicinoALagerholmCet al
In June 2025, Amgen announced positive Phase 2 trial results for MariTide showing up to ~20% weight loss in obese patients and ~17% in type 2 diabetes patients, presented at the ADA 85th scientific sessions
Foundayo is a once-daily pill Like the Wegovy pill, the new Foundayo pill is meant to be taken once a day, but the difference is that it can be taken any time of the day, with no food or water restrictions
Safety and metabolic effects of tesamorelin, a growth hormone-releasing factor analogue, in patients with type 2 diabetes: A randomized, placebo-controlled trial
Read the full article at #SleepMedicine #ObstructiveSleepApnea #PatientCare #GLP1 To view or add a comment, sign in More Relevant Posts If we are going to the trouble of performing a PSG, we should also go to the trouble of utilising this comprehensive, one night assessment more thoroughly, and use this to better individualise therapy management